The global cell-based assay market reached a value of around US$ 13.2 Billion in 2017. The market is currently being catalysed by a number of factors, this includes rising investments in research and development, adoption of high throughput screening methods, increasing prevalence of various chronic diseases, growth in drug discovery activities, and the various advantages that cell-based assays offer over alternative technologies. The market value is further expected to reach US$ 21.1 Billion by 2023, exhibiting a CAGR of around 8% during 2018-2023.

Cell-based assays refer to any experiment that use live cells. The basic techniques include a variety of assays that can be used for the purpose of measuring cell toxicity, proliferation, motility as well as production of a particular cellular product and cellular morphology. Cell-based assays provide a closer representation of the real life model since it employs live cells during experimentation. Cell-based assays have grown to become a versatile tool in healthcare research and development, particularly in the experiments which are designed to understand functionalities of specific cells like antibodies or drug efficacy on a group of cells.

There has been a significant increase in R&D funding by various public and private organisations so as to develop better and safer drugs. Moreover, technological advancements in cell-based assays have enabled researchers to start using this technology for drug discovery and toxicology studies. Another major factor catalysing the growth of the market is the rising prevalence of lifestyle diseases such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc. which still have large unmet needs and have led to continuous investments in R&D. In addition, an increase in the adoption of the cell-based assay techniques for high throughput screening methods like toxicity studies, drug screening, in vitro testing, etc. are further driving this market.

Market Summary:

Based on the product type, the market has been segmented as consumables, instruments, services and software. Currently, the consumables segment dominates the market, holding the largest share.
Based on the technology, the market has been segmented as automated handling, flow cytometry, label-free-detection, high-throughput screening, and others.
Based on the application, the market has been segmented as drug discovery, basic research, ADME studies, predictive toxicology and others. Currently, the drug discovery segment dominates the market, holding the largest share.
On the basis of end-user, the market has been segmented as pharmaceutical and biotechnology companies; academic and government institutions; contract research organizations; and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Amongst these, North America is the leading market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Becton Dickinson, Danaher Corporation, Thermo Fisher Scientific Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Charles River Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., Promega Corporation, Cisbio Bioassays, Cell Biolabs, Inc., Bio-Rad Laboratories, Inc., Corning, Inc. and F. Hoffmann-La Roche Ltd.

This report provides a deep insight into the global cell-based assay market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the cell-based assay market in any manner.

Key questions answered in this report:

  • How has the global cell-based assay market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global cell-based assay industry?
  • What are the key product and service types in the global cell-based assay industry?
  • What are the major technologies in the global cell-based assay industry?
  • What are the major application segments in the global cell-based assay industry?
  • What are the key end-use segments in the global cell-based assay industry?
  • What are the various stages in the value chain of the global cell-based assay market?
  • What are the key driving factors and challenges in the global cell-based assay market?
  • What is the structure of the global cell-based assay market and who are the key players?
  • What is the degree of competition in the global cell-based assay market?